Original Development Brief – Amends a series of sections throughout the Public Health Service Act to improve the treatment and understanding of pediatric cancers and late effects for survivors and their families.
Original Development Brief – Amends the Public Health Service Act to authorize sickle cell surveillance, prevention, and treatment initiatives and to establish conditions for collaboration with community-based organizations on such initiatives.
Original Development Brief – Examines and provides recommendations on the scientific, ethical, and social issues raised by human genome editing and assesses the capacity of governance systems to ensure the responsible development and use of this technology.
Original Development Brief – Grants FDA approval to the 23andMe Personal Genome Service (PGS) test as a Class II medical device for ten diseases and conditions and outlines special controls to mitigate risks involved.
Original Development Brief – Promotes and facilitates stem cell research showing evidence of substantial clinical benefit to patients, while placing restrictions on the creation, injury, and destruction of embryos for such research.